EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Latent change‐on‐change between amyloid accumulation and cognitive decline

Hannah M Klinger iD, Brian C Healy, Bernard J Hanseeuw, Rich N Jones, Rory Boyle, Diana L Townsend, Michael J Properzi, Gillian T Coughlan, Mabel Seto, Colin Birkenbihl, Michelle E Farrell, Kathryn V Papp und 10 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Hannah M Klinger und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Cognitive Dysfunction, Amyloid beta-Peptides, Aniline Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Massachusetts General Hospital/Harvard Medical School in Boston.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION While the influence of cross‐sectional β‐amyloid (Aβ) on longitudinal changes in cognition is well established, longitudinal change‐on‐change between Aβ and cognition is less explored. METHODS A series of bivariate latent change score models (LCSM) examined the relationship between changes in 11 C‐Pittsburgh Compound‐B (PiB) positron emission tomography (PET) and the Preclinical Alzheimer's Cognitive Composite‐5 (PACC‐5) while adjusting for covariates, including cross‐sectional medial temporal lobe (MTL) tau‐PET burden. We selected 352 clinically normal older participants with up to 9 years of PiB‐PET and PACC‐5 data from the Harvard Aging Brain Study (HABS). RESULTS Aβ accumulation was associated with subsequent cognitive decline beyond the effects of cross‐sectional Aβ burden. Within this model including covariates such as age, sex, and apolipoprotein ε4 ( APOE ε4) status, we found no evidence supporting previously published associations between cross‐sectional tau‐PET and cognitive intercept/slope. DISCUSSION Short‐term Aβ changes are significantly associated with cognitive decline in clinically normal older adults and may eclipse the effect of cross‐sectional Aβ and MTL tau. Highlights Aβ accumulation is associated with subsequent cognitive decline. High Aβ burden is not the sole metric signaling impending cognitive decline. Contrary to prior work, MTL tau‐PET and cognition were not associated in our models. Models of bivariate latent Aβ and cognitive change may eclipse the effects of MTL tau.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyCognitive DysfunctionAmyloid beta-PeptidesAniline CompoundsHumansMaleFemaleAgedCross-Sectional StudiesThiazolesBrainLongitudinal Studiestau ProteinsAged, 80 and overAlzheimer DiseaseNeuropsychological TestsTemporal Lobe

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid accumulationchange‐on‐changecognitive declinelatent change score modelsstructural equation models

Substanzen

Amyloid beta-PeptidesAniline CompoundsThiazoles2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoletau Proteins

Autor:innen und Institutionen

  • Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurology, Cliniques Universitaires Saint-Luc, Institute of Neurosciences, UCLouvain, Belgium.
  • Department of Psychiatry and Human Behavior, Brown University, Warren Alpert Medical School, Providence, Rhode Island, USA.
  • Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.

ORCID-Profile: Hannah M Klinger

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Massachusetts General Hospital/Harvard Medical School in Boston
  • Alzheimer's Association
  • National Institutes of Health

Zitieren

APA

Klinger, H. M., Healy, B. C., Hanseeuw, B. J., Jones, R. N., Boyle, R., Townsend, D. L., Properzi, M. J., Coughlan, G. T., Seto, M., Birkenbihl, C., Farrell, M. E., Papp, K. V., Chhatwal, J. P., Yang, H. S., Schultz, A. P., Amariglio, R. E., Jacobs, H. I. L., Price, J. C., Johnson, K. A., …, & Buckley, R. F. (2024). Latent change‐on‐change between amyloid accumulation and cognitive decline. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14326

Vancouver

Klinger HM, Healy BC, Hanseeuw BJ, Jones RN, Boyle R, Townsend DL, et al. Latent change‐on‐change between amyloid accumulation and cognitive decline. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14326

BibTeX
@article{Klinger2024,
  author = {Klinger, Hannah M and Healy, Brian C and Hanseeuw, Bernard J and Jones, Rich N and Boyle, Rory and Townsend, Diana L and Properzi, Michael J and Coughlan, Gillian T and Seto, Mabel and Birkenbihl, Colin and Farrell, Michelle E and Papp, Kathryn V and Chhatwal, Jasmeer P and Yang, Hyun-Sik and Schultz, Aaron P and Amariglio, Rebecca E and Jacobs, Heidi I L and Price, Julie C and Johnson, Keith A and Rentz, Dorene M and Sperling, Reisa A and Buckley, Rachel F},
  title = {Latent change‐on‐change between amyloid accumulation and cognitive decline},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14326}
}
Kostenlos starten →